We’re thrilled to welcome you as a new member of our journal. Your support helps advance scholarly research and ensures access to cutting-edge psychiatry articles and insights.
Thank You for Joining Our Academic Community!
Personalize Your Experience
Help us customize your content and recommendations by verifying your professional credentials with your National Provider Identifier (NPI).
Note: You’ll need to log in or create an account to save your NPI information.
Do you have an NPI number?
Choose your interests
Select topics that interest you to receive personalized recommendations and content.
Our Recently Published Articles
Original Research
Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life
August 11, 2025
Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.
Original Research
The Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US
August 11, 2025
Medical Expenditure Panel Survey data showed that over half of adults with schizophrenia report cognitive impairments, which were associated with higher healthcare costs and lower quality of life.
Original Research
Onfasprodil (MIJ821) in Patients with Treatment-Resistant Depression: A Phase 2, Randomized, Placebo-Controlled, Proof-of-Concept Study
August 6, 2025
Onfasprodil appeared to be effective and well-tolerated across all dosing regimens in patients with TRD and demonstrated rapid onset of action (24 hours) with evidence of antidepressant effects to…
